Pascal Lapierre

2.7k total citations
47 papers, 1.8k citations indexed

About

Pascal Lapierre is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Pascal Lapierre has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 28 papers in Epidemiology and 10 papers in Rheumatology. Recurrent topics in Pascal Lapierre's work include Liver Diseases and Immunity (22 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis B Virus Studies (10 papers). Pascal Lapierre is often cited by papers focused on Liver Diseases and Immunity (22 papers), Liver Disease Diagnosis and Treatment (20 papers) and Hepatitis B Virus Studies (10 papers). Pascal Lapierre collaborates with scholars based in Canada, United States and United Kingdom. Pascal Lapierre's co-authors include Fernando Álvarez, Kathie Béland, Idriss Djilali-Saiah, Marc Bilodeau, Shamir Cassim, Valérie‐Ann Raymond, Jean‐Claude Homberg, O. Hajoui, Alain Lamarre and Grant A. Mitchell and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Pascal Lapierre

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Lapierre Canada 24 1.0k 856 325 246 240 47 1.8k
Ludger Leifeld Germany 26 824 0.8× 810 0.9× 227 0.7× 528 2.1× 477 2.0× 73 2.1k
Marie‐Luise Berres Germany 26 1.0k 1.0× 1.0k 1.2× 358 1.1× 524 2.1× 337 1.4× 59 2.1k
K Tanikawa Japan 21 927 0.9× 855 1.0× 303 0.9× 264 1.1× 321 1.3× 61 1.8k
O Gressner Germany 23 801 0.8× 871 1.0× 847 2.6× 174 0.7× 240 1.0× 44 2.1k
Masaru Enomoto Japan 27 1.6k 1.6× 1.6k 1.9× 441 1.4× 104 0.4× 236 1.0× 165 2.6k
Toshio Morizane Japan 22 509 0.5× 518 0.6× 224 0.7× 160 0.7× 324 1.4× 82 1.3k
Michiari Okuda Japan 15 1.2k 1.2× 1.2k 1.4× 355 1.1× 131 0.5× 86 0.4× 28 1.9k
Eiji Kakazu Japan 24 692 0.7× 927 1.1× 781 2.4× 241 1.0× 179 0.7× 75 2.0k
Karl-Hermann Meyer zum Büschenfelde Germany 17 502 0.5× 582 0.7× 328 1.0× 869 3.5× 125 0.5× 24 1.9k
Paola Ceppa Italy 22 598 0.6× 784 0.9× 176 0.5× 187 0.8× 554 2.3× 59 1.8k

Countries citing papers authored by Pascal Lapierre

Since Specialization
Citations

This map shows the geographic impact of Pascal Lapierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Lapierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Lapierre more than expected).

Fields of papers citing papers by Pascal Lapierre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Lapierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Lapierre. The network helps show where Pascal Lapierre may publish in the future.

Co-authorship network of co-authors of Pascal Lapierre

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Lapierre. A scholar is included among the top collaborators of Pascal Lapierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Lapierre. Pascal Lapierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lapierre, Pascal & Fernando Álvarez. (2022). Type 2 autoimmune hepatitis: Genetic susceptibility. Frontiers in Immunology. 13. 1025343–1025343. 11 indexed citations
2.
Chan, Tom S., Shamir Cassim, Valérie‐Ann Raymond, et al.. (2018). Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia. PLoS ONE. 13(6). e0199177–e0199177. 30 indexed citations
3.
4.
Coisne, Augustin, Pascal Lapierre, Marie Fertin, et al.. (2017). Quality of life in outpatients with hypertrophic cardiomyopathy. Archives of Cardiovascular Diseases Supplements. 9(1). 34–34. 1 indexed citations
5.
Cassim, Shamir, Valérie‐Ann Raymond, Pascal Lapierre, & Marc Bilodeau. (2017). From in vivo to in vitro: Major metabolic alterations take place in hepatocytes during and following isolation. PLoS ONE. 12(12). e0190366–e0190366. 40 indexed citations
6.
Cassim, Shamir, Marc Bilodeau, Catherine Vincent, & Pascal Lapierre. (2017). Novel Immunotherapies for Autoimmune Hepatitis. Frontiers in Pediatrics. 5. 8–8. 15 indexed citations
7.
Lapierre, Pascal, et al.. (2015). Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells. Cellular and Molecular Gastroenterology and Hepatology. 1(3). 325–341.e1. 10 indexed citations
8.
Janelle, Valérie, et al.. (2014). The Strength of the T Cell Response Against a Surrogate Tumor Antigen Induced by Oncolytic VSV Therapy Does Not Correlate With Tumor Control. Molecular Therapy. 22(6). 1198–1210. 15 indexed citations
9.
Janelle, Valérie, et al.. (2013). Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells. Cancer Immunology Research. 2(3). 200–206. 43 indexed citations
10.
Lapierre, Pascal, et al.. (2012). Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance. Hepatology. 57(1). 217–227. 88 indexed citations
11.
Halac, Ugur, Kathie Béland, Pascal Lapierre, et al.. (2012). Cirrhosis due to Chronic Hepatitis E Infection in a Child Post-Bone Marrow Transplant. The Journal of Pediatrics. 160(5). 871–874.e1. 59 indexed citations
12.
Janelle, Valérie, et al.. (2011). Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy. Journal of Virology. 85(13). 6513–6520. 22 indexed citations
13.
Lapierre, Pascal, et al.. (2011). Structural Basis for Broad Neutralization of Hepatitis C Virus Quasispecies. PLoS ONE. 6(10). e26981–e26981. 11 indexed citations
14.
Lapierre, Pascal, et al.. (2010). Forkhead Box P3+ Regulatory T Cell Underlies Male Resistance to Experimental Type 2 Autoimmune Hepatitis. Hepatology. 51(5). 1789–1798. 35 indexed citations
15.
Lapierre, Pascal & Fernando Álvarez. (2007). Le foie : un organe du système immunitaire ?. médecine/sciences. 23(11). 985–990. 3 indexed citations
16.
Lapierre, Pascal, et al.. (2004). Anti-Soluble Liver Antigen (SLA) Antibodies in Chronic HCV Infection. Autoimmunity. 37(3). 217–222. 26 indexed citations
17.
Béland, Kathie, Pascal Lapierre, Gabriel Marceau, & Fernando Álvarez. (2004). Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. Journal of Autoimmunity. 22(2). 159–166. 22 indexed citations
18.
Lapierre, Pascal, et al.. (2003). Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis. Experimental Cell Research. 292(2). 332–341. 10 indexed citations
19.
Djilali-Saiah, Idriss, et al.. (2002). DNA Vaccination Breaks Tolerance for a Neo-Self Antigen in Liver: A Transgenic Murine Model of Autoimmune Hepatitis. The Journal of Immunology. 169(9). 4889–4896. 45 indexed citations
20.
Lapierre, Pascal, O. Hajoui, Jean‐Claude Homberg, & Fernando Álvarez. (1999). Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology. 116(3). 643–649. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ludger Leifeld Breakdown of academic impact, for papers by Marie‐Luise Berres Breakdown of academic impact, for papers by K Tanikawa Breakdown of academic impact, for papers by O Gressner Breakdown of academic impact, for papers by Masaru Enomoto Breakdown of academic impact, for papers by Toshio Morizane Breakdown of academic impact, for papers by Michiari Okuda Breakdown of academic impact, for papers by Eiji Kakazu Breakdown of academic impact, for papers by Karl-Hermann Meyer zum Büschenfelde Breakdown of academic impact, for papers by Paola Ceppa
Rankless by CCL
2026